Analyst Ratings for FibroGen (FGEN) [Buys]
FGEN Rating Summary
FGEN Price Target Summary
- Highest: $11.00 (Stifel)
- Lowest: $2.00 (Goldman Sachs)
- Average: $4.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.50 (+284.6%)
* Over Last 12-Mos
Rating Score: 2.1 / 10
Percentile Rank: 16%
Avg. $ Target:
$4.50 (+284.6%)
* Over Last 12-Mos
Rating Score: 2.1 / 10
Percentile Rank: 16%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2018 | Citi » Updated 3/19/2020 |
Joel Beatty | Upgrade | Buy (Neutral) |
51.00 (65.00) |
38.99 (1.17) |
-97% | Details |
| 2/11/2016 | Credit Suisse | N/A | Upgrade | Outperform (Neutral) |
40.00 (N/A) |
15.08 (1.17) |
-92.24% | Details |
 |
||||||||
